6550--MPLS - Unrestricted - Supply IDIQ Lab Blood Bank Automation Pre-Solicitation Notice
Veterans Affairs · NETWORK CONTRACT OFFICE 23 (36C263)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C26325R0037 in this department, oldest first.
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
Blood Bank Automation System IDIQ Q&A On page 61 Section B.4 Statement of Work 1. Basic Requirement, it states: The analyzers may be placed in a temporary location for validation and need to be moved to a permanent location after they re validated� for use.� Contractor� will be responsible for moving analyzers for this one time move, at no cost to the Government.� � Can you please provide information on where the temporary location will be and the permanent location?� � Will it be the same building, same floor, etc.? Same room but different counter space. Minimal moving required. On page 62 Se… (show all)
ction B.4 Statement of Work 3. Technical Requirements & Salient Characteristics, it states, "m. Primary analyzer must be capable of performing the following tests" and indicates Crossmatch (IS and AHG) We understand that IS Crossmatch is one of the technical requirements that the primary analyzer 'must be capable of'. We are wondering if you are open to accept other technical solutions that Bio-Rad can offer, such as our IH-500 NEXT which does AHG Crossmatch but does not do IS Crossmatch." No. It has to have a way to perform ABO compatibility outside of IgG card. Unless you have validation stating your IgG card can detect ABO incompatibility.
Who won similar work
6 award notices on SAM.gov in the last 24 months. Matched by: Same office (NETWORK CONTRACT OFFICE 23 (36C263)), same product/service code (PSC) 6550 and NAICS 325413.
Single-winner award sizes (6): middle half $159K to $345K, median $273K; range $82K to $771K.
| Winner | Awards | Value | Last |
|---|---|---|---|
| MICROGENICS CORPORATION · $TMO · $46.3B | 2 | $852K | Jan 10, 2025 |
| BIOMERIEUX INC | 2 | $650K | Oct 1, 2026 |
| Roche Diagnostics Minneapolis MN 55417 USA | 1 | $263K | Jun 21, 2026 |
| PROMEGA CORPORATION | 1 | $124K | Jun 1, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $TMO reported $46.3B revenue (12 months to Jun 27, 2026). The median single-winner award in these 6 past awards, $273K, is under 0.1% of that. SEC filing
One award's total value against one year of revenue; many awards are paid over several years.
- Oct 1, 2026BIOMERIEUX INC$284K6550--DO Biofire Panel Kits in support of the Sioux Falls VA HCSNo listed company matched (Materiality N/A)
- Jun 21, 2026Roche Diagnostics Minneapolis MN 55417 USA$263K6550--(IHC) Staining System - MPLSNo listed company matched (Materiality N/A)
- Jun 1, 2026PROMEGA CORPORATION$124K6550--DNA Extraction ReagentsNo listed company matched (Materiality N/A)
- Apr 24, 2025BIOMERIEUX INC$366KBlood Culture Testing Equipment and ServicesNo listed company matched (Materiality N/A)
- Jan 10, 2025MICROGENICS CORPORATION$82K6550--MPLS - Microgenics DRI Ecstasy Plus Assay Reagents Supply Contract Award NoticeMateriality: <0.01% of $TMO revenue (Low) SEC
- Dec 5, 2024MICROGENICS CORPORATION$771K6550--MPLS - Toxicology Drugs of Abuse Supplies Reagents, Calibrators, and Controls for AssaysMateriality: <0.01% of $TMO revenue (Low) SEC
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 4 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 2 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (7 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $40K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 7 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 1 of the past winners are listed companies
- 0 insider buys and 7 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.